Tweet
Hum Vaccin Immunother. 2012 Oct 9;9(1). [Epub ahead of print]
Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India.
Tandale BV, Pawar SD, Gurav YK, Parkhi SS, Mishra AC.
Source
National Institute of Virology; Pashan, Pune India.
Abstract
The healthcare workers with having seroprotection at 3 weeks (n=127) following Pandemic H1N1 2009 influenza vaccination were followed up for antibody persistence. Seroprotection at 12 months (60.2%) was significantly lower as compared to 3 weeks (74.7%), 3 months (77.8%) and 6 months (75.4%). The vaccine provided seroprotection up to one year.
PMID:
23047369
[PubMed - as supplied by publisher]
Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India.
Tandale BV, Pawar SD, Gurav YK, Parkhi SS, Mishra AC.
Source
National Institute of Virology; Pashan, Pune India.
Abstract
The healthcare workers with having seroprotection at 3 weeks (n=127) following Pandemic H1N1 2009 influenza vaccination were followed up for antibody persistence. Seroprotection at 12 months (60.2%) was significantly lower as compared to 3 weeks (74.7%), 3 months (77.8%) and 6 months (75.4%). The vaccine provided seroprotection up to one year.
PMID:
23047369
[PubMed - as supplied by publisher]
